Neue Erkenntnisse zu Fumarsäureestern (Fumaderm®): Ergebnisse des 2. Experten‐Workshops

Ulrich Mrowietz, Peter Altmeyer, Matthias Augustin, Wolf-Henning Boehncke, Bernd Bonnekoh, Yvonne Frambach, Thilo Gambichler, Kamran Ghoreschi, Michael Hertl, Anna-Carina Hund, Arnd Jacobi, Annegret Kuhn, Ralf J Ludwig, Thomas Luger, Stefan F Martin, Hans Merk, Johannes Norgauer, Kristian Reich, Martin Rostami-Yazdi, Robert Sabat, Knut Schäkel, Karin Scharffetter-Kochanek, Michael Peter Schön, Nina Scola, Michael Sticherling, Diamant Thaci, Dagmar Wilsmann-Theis, Antje Viehweg, Gottfried Wozel, Christos C. Zouboulis, Marcus Neureither

[1]  W. Boehncke,et al.  The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity , 2011, Experimental dermatology.

[2]  Wolf-Henning Boehncke,et al.  Reduced TRPC Channel Expression in Psoriatic Keratinocytes Is Associated with Impaired Differentiation and Enhanced Proliferation , 2011, PloS one.

[3]  S. Fichtlscherer,et al.  Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial , 2011, Archives of Dermatological Research.

[4]  D. Zillikens,et al.  NADPH oxidase is required for neutrophil‐dependent autoantibody‐induced tissue damage , 2007, The Journal of pathology.

[5]  K. Scharffetter-Kochanek,et al.  TGF-beta-dependent suppressive function of Tregs requires wild-type levels of CD18 in a mouse model of psoriasis. , 2008, The Journal of clinical investigation.

[6]  K. Schäkel,et al.  Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responses. , 2011, The Journal of allergy and clinical immunology.

[7]  K. Reich,et al.  Versorgungsqualität der Psoriasis vulgaris in Deutschland – Ergebnisse der Nationalen Versorgungsstudie PsoHealth 2007 , 2008 .

[8]  K. Reich,et al.  Psoriasis--new insights into pathogenesis and treatment. , 2009, Deutsches Arzteblatt international.

[9]  I. Schaefer,et al.  Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany. , 2010, Acta dermato-venereologica.

[10]  K. Asadullah,et al.  The Th17 cytokine IL‐22 induces IL‐20 production in keratinocytes: A novel immunological cascade with potential relevance in psoriasis , 2009, European journal of immunology.

[11]  Enno Schmidt,et al.  Genetic identification and functional validation of FcγRIV as key molecule in autoantibody‐induced tissue injury , 2012, The Journal of pathology.

[12]  P. Altmeyer,et al.  [Efficacy and safety profile of fumaric acid esters in oral long-term therapy with severe treatment refractory psoriasis vulgaris. A study of 83 patients]. , 1996, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[13]  T. Luger,et al.  Neue Erkenntnisse zu Fumarsäureestern (Fumaderm®): Ergebnisse eines Experten‐Workshops , 2011 .

[14]  Henning Hofmeister,et al.  In-situ-topoproteome analysis of cutaneous lymphomas: perspectives of assistance for dermatohistologic diagnostics by Multi Epitope Ligand Cartography (MELC). , 2008, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[15]  P. Altmeyer,et al.  Treatment of therapy-resistant Alopecia areata with fumaric acid esters. , 2006, European journal of medical research.

[16]  D. Bengel,et al.  Functional Energetics of CD4+-Cellular Immunity in Monoclonal Antibody-Associated Progressive Multifocal Leukoencephalopathy in Autoimmune Disorders , 2011, PloS one.

[17]  H. Volk,et al.  IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not , 2009, Journal of Molecular Medicine.

[18]  K. Reich,et al.  [15 years of fumaderm: fumaric acid esters for the systemic treatment of moderately severe and severe psoriasis vulgaris]. , 2009, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[19]  I. Schaefer,et al.  Prevalence of Skin Diseases in a Cohort of 48,665 Employees in Germany , 2008, Dermatology.

[20]  K. Schäkel,et al.  Human 6-sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are controlled by erythrocytes. , 2006, Immunity.

[21]  K. Asadullah,et al.  Interleukin (IL)‐19, IL‐20 and IL‐24 are produced by and act on keratinocytes and are distinct from classical ILs , 2006, Experimental dermatology.

[22]  T. Gambichler,et al.  Monitoring peripheral blood CD4(+) intracellular adenosine triphosphate concentration in patients with psoriasis treated with fumaric acid esters. , 2012, Acta dermato-venereologica.

[23]  A. Gottlieb,et al.  Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. , 2009, Journal of the American Academy of Dermatology.

[24]  P. Altmeyer,et al.  Fumaric Acid Esters Suppress Peripheral CD4- and CD8-Positive Lymphocytes in Psoriasis , 1998, Dermatology.

[25]  M. Friedrich,et al.  S3‐Leitlinie zur Therapie der Psoriasis vulgaris , 2006 .

[26]  H. Volk,et al.  Deficiency of IL-22 Contributes to a Chronic Inflammatory Disease: Pathogenetic Mechanisms in Acne Inversa , 2011, The Journal of Immunology.

[27]  K. Asadullah,et al.  IL‐22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis , 2006, European journal of immunology.

[28]  J. Lademann,et al.  UVB-induced DNA damage, generation of reactive oxygen species, and inflammation are effectively attenuated by the flavonoid luteolin in vitro and in vivo. , 2011, Free radical biology & medicine.

[29]  J. Ring,et al.  Mutual antagonism of T cells causing psoriasis and atopic eczema. , 2011, The New England journal of medicine.

[30]  Ludwig Kappos,et al.  Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study , 2008, The Lancet.

[31]  T. Horio,et al.  Heightened ability of monocytes from sarcoidosis patients to form multi‐nucleated giant cells in vitro by supernatants of concanavalin A‐stimulated mononuclear cells , 2001, Clinical and experimental immunology.

[32]  R. Paus,et al.  Lymphocytes, neuropeptides, and genes involved in alopecia areata. , 2007, The Journal of clinical investigation.

[33]  K. Reich,et al.  Nail psoriasis in Germany: epidemiology and burden of disease , 2010, The British journal of dermatology.

[34]  D. Zillikens,et al.  Heat-shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets. , 2011, Blood.

[35]  K. Asadullah,et al.  IL-22 increases the innate immunity of tissues. , 2004, Immunity.

[36]  T. Luger,et al.  Efficacy and safety of fumaric acid esters in the long‐term treatment of psoriasis – A retrospective study (FUTURE) , 2009, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[37]  M. Idzko,et al.  Lack of the purinergic receptor P2X7 results in resistance to contact hypersensitivity , 2010, The Journal of experimental medicine.

[38]  Stefan Bereswill,et al.  Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity , 2008, The Journal of experimental medicine.

[39]  P. Lipsky,et al.  TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. , 2006, Blood.

[40]  Navjeevan Singh,et al.  A study of clinicohistopathological correlation in patients of psoriasis and psoriasiform dermatitis. , 2009, Indian journal of dermatology, venereology and leprology.

[41]  W. Boehncke,et al.  Interleukin-1β interferes with epidermal homeostasis through induction of insulin resistance: implications for psoriasis pathogenesis. , 2012, The Journal of investigative dermatology.

[42]  Andreas Natsch,et al.  Skin sensitizers induce antioxidant response element dependent genes: application to the in vitro testing of the sensitization potential of chemicals. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[43]  Thomas Vogl,et al.  Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel , 2010, Nature Immunology.

[44]  Walter E. Müller,et al.  Specific TRPC6 Channel Activation, a Novel Approach to Stimulate Keratinocyte Differentiation* , 2008, Journal of Biological Chemistry.

[45]  Detlef Zillikens,et al.  FcγRIIA and FcγRIIIB are required for autoantibody-induced tissue damage in experimental human models of bullous pemphigoid. , 2010, The Journal of investigative dermatology.

[46]  Martin Röcken,et al.  Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells , 2012 .

[47]  W. Schubert,et al.  Analyzing proteome topology and function by automated multidimensional fluorescence microscopy , 2006, Nature Biotechnology.

[48]  G Glaeske,et al.  Epidemiology and comorbidity of psoriasis in children , 2010, The British journal of dermatology.

[49]  K. Scharffetter-Kochanek,et al.  CD18 in monogenic and polygenic inflammatory processes of the skin. , 2006, The journal of investigative dermatology. Symposium proceedings.